INS and diabetes mellitus: Several policy solutions have been proposed, and a few, such as state co-pay caps for insulin and the recent Inflation Reduction Act (IRA) (which allows Medicare negotiation on certain drugs including several for diabetes and implemented a $35 copay cap on insulin for Medicare recipients) have started to address affordability concerns for diabetes care.